The method, called optical coherence refraction tomography, could improve medical images obtained in the OCT imaging industry for medical fields ranging from cardiology to oncology.
The approach involves using an ophthalmoscope attached to the lens of a smartphone camera to acquire video of blood vessels.
The company is working to further the use of bioprinted tissues in ophthalmology.
The laser refractive surgery method has been in development for more than 15 years and has now entered clinical trials.
The monitor achieves results comparable to clinical OCT in a study measuring retinal thickness in healthy eyes.
Carl Zeiss Meditec has received U.S. FDA premarket approval for the ReLEx SMILE PMA ultrafast laser procedure.
OCT technology provided evidence that suggests Alzheimer's disease in older patients who had no symptoms of the disease.
The handheld optical imager, which can image individual photoreceptors in the eye, will enable improved diagnosis of eye diseases.
Optical coherence tomography angiography (OCTA) has achieved another milestone: mainstreaming of quantification.
The optical coherence tomography angiography blood vessel measurement technology helps clinicians manage diseases that cause progressive blindness.
The noninvasive ultrafast laser approach could lead to treatment for myopia, hyperopia, astigmatism, and irregular astigmatism.
A next-generation version of the Spectralis optical coherence tomography (OCT) imaging platform is headed for the International Space Station (ISS).
The researchers used OCT (which is noninvasive) to image the retinas of survivors with this Ebola retinal scar.
The financing provides support for a low-cost, noninvasive eye imaging system for Alzheimer's disease detection.
The approval expands the platform's capabilities to include the creation of the corneal pockets and flaps used in ophthalmic procedures.